(Photo: iStock)

The Medicines and Health products Regulatory Agency (MHRA) has issued a class two medicines recall for Epilim 500mg gastro-resistant tablets (PL 04425/0303) of Sanofi.

Sanofi has informed the MHRA that it is recalling the product batches as a precautionary measure due to out of specification results for disintegration test during routine stability testing.

Product details

Batch Number Expiry Date Pack Size First Distributed
R0601 08/2022 30 November 6, 2019
R0602 08/2022 30 November 5, 2019
R0603 08/2022 30 November 6, 2019

The healthcare professionals have been advised to stop supplying the product batches immediately and quarantine all stock and return it to their supplier using their supplier’s approved process.

If you want to share your stories and/or experiences with us, please send an email to [email protected]

LEAVE A REPLY